4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-032330
EVP, Research & CSO sold 3,805 shares at $34.08 ($129,674)
- EVP, Research & CSO acquired 3,805 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-05-26 | Option exercise | +3,805 | $1.53 | $5,822 | 3,805 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2020-05-26 | Sale | −3,805 | $34.08 | $129,674 | 0 | D: show line 2 in the form |
| Open-market sales · 3,805 sh · avg $34.08 · $129,674 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-05-26 | Option exercise · Stock Option (Right to Buy) | −3,805 | 546,190 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…